The Ozempic Craze: Weight Loss and Black Market Demand.

Novo Nordisk, Eli Lilly, and WW International are three companies that could benefit from the popularity of Ozempic, a drug that has been effective in helping people lose weight. Novo Nordisk, the maker of Ozempic, is likely to see the biggest benefit, with its higher-dose treatment, Wegovy, also showing promise. Eli Lilly has its own weight-loss treatment, Mounjaro, which could potentially be the best-selling drug ever. WW International recently acquired Sequence, a telehealth platform that offers prescriptions for Ozempic and Wegovy, which could lead to growth for the struggling weight-loss brand.